Table 1 Demographic and clinical characteristics of the study cohort.
Demographic | Number of patients (%) |
---|---|
Male sex (%) | 81 (51.6%) |
Age, mean (± SD) years | 47.61 (± 14.7) |
Etiology of liver disease | |
NAFLD | 53 (33.8%) |
Viral Hepatitis | 42 (26.8%) |
Cholestatic liver disease | 15 (9.6%) |
Autoimmune Hepatitis | 9 (5.7%) |
Other diagnoses (including NYD) | 32 (20.4%) |
Normal liver biopsies | 6 (3.8%) |
Liver fibrosis stage histology | |
F0 | 27 (17.2%) |
F1 | 20 (12.7%) |
F2 | 15 (9.6%) |
F3 | 28 (17.8%) |
F4 | 67 (42.7%) |
VCTE | |
Mean LSM (± SD) kPa | 15.47 (± 14.51) |
≥ 9.6 kPa | 82 (52.2%) |
> 10.2 kPa | 75 (47.8%) |
Ultrasound parameters | |
Liver surface nodularity | 46 (29.3%) |
Lobar redistribution | 38 (24.5%) |
Hepatic vein nodularity | 28 (18.1%) |